Pancreatic Cancer Europe is a European multi-stakeholder platform which aims at bringing together experts from all over Europe including academics, physicians, politicians, patient groups, journalists and industry with a common interest and willingness to improve care for patients with pancreatic cancer.

News

“Innovation in Pancreatic Cancer Treatment”, recording and speakers’ presentations are online

On 28 June 2022, PCE held an International Workshop focused on Innovation in Pancreatic Cancer Treatment. The online event, addressed to practitioners, professionals and patient organizations, has been a great occasion for sharing information on innovative treatments for the disease. » Click here to watch the workshop recording  Download the speakers’ presentations for free: Alfredo…   …Read More »“Innovation in Pancreatic Cancer Treatment”, recording and speakers’ presentations are online

“Nutrition and quality of life in pancreatic cancer patients”, recording and speakers’ presentations are online

In the morning of 22 June 2022, in the frame of the 54th European Pancreatic Club Meeting (22-25 June 2022), PCE held the workshop “Nutrition and quality of life in pancreatic cancer patients”. One of PCE commitments is to raise awareness on the importance of a high quality diet for better react to cancer treatments, and…   …Read More »“Nutrition and quality of life in pancreatic cancer patients”, recording and speakers’ presentations are online

PancreOS presentation seminar, 30 June 2022

PancreOS is a long-term project promoted by PCE. It aims at implementing an European network of pancreatic cancer registries to improve the collection of comprehensive set of prospective data from pancreatic cancer patients at any stage of the disease, and creating connections among the existing registries on pancreatic cancer in Europe. During the seminar, PCE…   …Read More »PancreOS presentation seminar, 30 June 2022

“Innovation in Pancreatic Cancer Treatment”, 28 June 2022

PCE promotes an international workshop focused on Innovation in Pancreatic Cancer Treatment, on 28 June from 15:30 to 17:00 (CEST). The event aims at sharing information on innovative treatments for pancreatic cancer and promoting the exchange of best practices and experiences among practitioners, professionals, patients, patient organizations and other relevant stakeholders. To register for the…   …Read More »“Innovation in Pancreatic Cancer Treatment”, 28 June 2022

PCE Workshop “Nutrition and quality of life in pancreatic cancer patients”, in the frame of EPC Meeting, 22 June 2022

On 22 June 2022, from 9:00 to 10:00 (CEST), PCE will run a on line workshop in the frame of the 54th European Pancreatic Club Meeting. The workshop, proposed by PCE, focuses on Nutrition and quality of life in pancreatic cancer patients. The workshop is addressed to gastroeneterologists, surgeons and oncologists dealing with pancreatic cancer.…   …Read More »PCE Workshop “Nutrition and quality of life in pancreatic cancer patients”, in the frame of EPC Meeting, 22 June 2022

PCE Early Career Investigator (ECI) Short-term Scientific Stay Award (S3A) – 2022

  THE ORGANISATION  The Pancreatic Cancer Europe (PCE) is a European multi-stakeholder platform, which aims at bringing together experts from all over Europe including academics, physicians, politicians, patient groups, journalists and industry with a common interest and willingness to improve care for patients with pancreatic cancer.  THE AWARD  PCE launches a call for a short-term…   …Read More »PCE Early Career Investigator (ECI) Short-term Scientific Stay Award (S3A) – 2022

Pancreatic Cancer Heatmap now online!

Following several months of development, we are happy to unveil the PCE heatmap. Conceived as a powerful tool to compare the pancreatic cancer patients’ situation in each European country, the heatmap provides information on awareness situation, national policy, diagnosis, research… We are always looking for more data and information to enrich the heatmap. Should you want to add some data for your country, please contact directly the Secretariat.

Visit the PCE heatmap ›

Did you know that Pancreatic Cancer has the lowest survival rate of all cancers?

pancreatic cancer europe

Help us to reverse the Trend!

Pancreatic cancer is currently the 4th leading cause of death by cancer in Europe. If no action is taken, it is set to be 2nd by 20203.

Launched in July 2014 a call for action on pancreatic cancer by Members of the European Parliament has been the key driver for the activities of the platform. Since its launch, Pancreatic Cancer Europe has been developping the Pancreatic Cancer Declaration, in order to ensure real change in European policies for pancreatic cancer patients.

Pancreatic cancer is currently the 4th leading cause of death by cancer in Europe. If no action is taken, it is set to be 2nd by 20203.

Patients affected with pancreatic cancer lose 98% of their healthy life expectancy at the point of diagnosis5.

Today, a diagnosis of pancreatic cancer is generally associated with a death sentence and few patients are alive one year after diagnosis, while an earlier diagnosis could help reduce the mortality of the disease. If diagnosed in time, chances of survival increase.

  1. Farthing, M, Roberts, S, Samuel D, Williams D, et al. Survey of digestive health across Europe: Final report. Part 1: The burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe, United European Gastroenterology Journal, December 2014 vol. 2 no. 6 539-543
  2. Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E, et al. European cancer mortality predictions for the year 2013. Annals of Oncol. 2013; 24:792-800
  3. Pancreatic Cancer Action Network. The alarming rise of pancreatic cancer deaths in The United States: Why we need to stem the tide today, 2012. www.pancan.org/wp-content/uploads/2013/01/incidence_report_2012_executive_summary.pdf [Last accessed April 2014]
  4. Carrato et al, 2015. “A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs.” DOI 10.1007/s12029-015-9724-1
  5. Carrato A, Falcone A, Ducreux, M, Valle, J, Parnaby A, Djazouli K, Alnwick-Allu K, Hutchings A, Palaska C, Parthenaki I. A systematic review of the burden of pancreatic cancer in Europe: Real-world impact on survival, quality-of-life, and costs. J Gastrointest Cancer 2015 Sep;46(3):201-11